Wednesday 12 December 2018 ,
Latest News
  • EC starts allocating electoral symbols to candidates
  • Hasina to flag off election campaign from Tungipara Dec 12
  • 29 JaPa candidates to contest polls under Grand Alliance; 143 independently
  • HC orders EC to accept Hero Alam’s nomination
  • HC decision on Khaleda’s candidacy Tuesday
2 December, 2017 07:04:33 PM

Print

Philippines 'prepared for worst' in dengue vaccine concerns

Independent Online Desk
Philippines 'prepared for worst' in dengue vaccine concerns

The Philippines is prepared for a "worst-case scenario" following warnings that an anti-dengue vaccine administered to thousands of children may worsen the disease in some cases, a health official said Saturday.

Department of Health spokesman Eric Tayag said the country had already taken precautions against potential mishaps when it became the first country to use the landmark vaccine in 2016.

The developer of the world's first vaccine for the potentially deadly virus, French pharmaceutical giant Sanofi, revealed earlier this week that it could trigger more severe symptoms in people who had not been previously infected with dengue.

More than 733,000 children have already received Dengvaxia, raising fears that many could develop the harsher form of the disease.

"The Department of Health is prepared for a worst-case scenario," Tayag told ABS-CBN television, a day after the agency announced it was suspending its mass vaccination programme.

Tayag said the government had been careful to only implement the scheme in areas where dengue was already widespread and had only given it to children aged nine or older.

"They are being followed up for adverse effects following immunisation," he said.

He added that the department, which had previously said there were no reported cases of worsened infection among those who received the vaccine, was also checking hospital records for severe cases of dengue.

Sanofi had said such acute dengue cases would not become apparent till about five years after vaccination, Tayag added.

The developer initially said its Dengvaxia vaccine was "critical" in the fight against dengue, the world's most common mosquito-borne virus.

It said Wednesday that a new study has confirmed Dengvaxia's benefits for "those who had prior infection" with the potentially-lethal disease.

"For those not previously infected by dengue virus, however, the analysis found that in the longer term, more cases of severe disease could occur following vaccination upon a subsequent dengue infection," Sanofi said.

More than 1,000 people in the Philippines died from dengue last year, out of more than 211,000 suspected cases, according to the government.AFP.

KK

.

Comments

Poll
Today's Question »
The US ambassador in Dhaka yesterday said his country doesn’t support any candidate or party in the upcoming national polls. DO you support the statement?
 Yes
 No
 No Comment
Yes 70.6%
No 17.6%
No Comment 11.8%
Video
More Health Stories

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting